To increase our understanding of the contribution of GIPR variants to metabolic health, the aim of our study was to (1) establish the association of three SNVs, rs11672660, rs2334255 and rs10423928, with the risk of excessive body mass and MS; and (2) investigate their association with anthropometric measurements and selected metabolic parameters in the Polish population. Here, GIPR is linked to myeloid sarcoma.